The Hsp90 inhibitor IPI-504 rapidly lowers EML4–ALK levels and induces tumor regression in ALK-driven NSCLC models

✍ Scribed by Normant, E; Paez, G; West, K A; Lim, A R; Slocum, K L; Tunkey, C; McDougall, J; Wylie, A A; Robison, K; Caliri, K

• Book ID: 109972736
• Publisher: Nature Publishing Group
• Year: 2011
• Tongue: English
• Weight: 397 KB
• Volume: 30
• Category: Article
• ISSN: 0950-9232
• DOI: 10.1038/onc.2010.625